Investigative Trial of Interferon Alpha-2b To Shrink Cancer of the Eye

Summary

The purpose of this study is to explore whether the drug pegylated-interferon-alfa-2b (PEG-IFN) has any effect on a certain type of immune cell (called natural killer cells) in patients with eye melanoma.

Timeline

Start

2007-03

Primary completion

2008-06

Completion

—

Outcome

Outcome not reported

Stopped (Business): “no funding- study never began”

Drugs

Indications